Press-release for stocks related to covid

Prices are updated after-hours

tags : Covid crawled time : 20:00

save search

60 Degrees Pharma Withdraws COVID Phase IIB IND, Will Resubmit Pending Assessment of Ability to Meet FDA Requirements
Published: 2023-09-18 (Crawled : 20:00) - globenewswire.com
SXTP | $0.245 -0.57% -0.57% 92K

n/a

| -78.35% | O: -26.39% H: 9.41% C: 1.24%
fda pharma covid

COVID Drug Maker Tevogen To Go Public Via SPAC At $1.2B – Law360
Published: 2023-06-29 (Crawled : 20:00) - spacfeed.com
USCT | $11.23 0.27% 210

n/a

| Email alert Add to watchlist
drug covid spac

LumiraDx Receives UK CTDA Approval for COVID Ultra and COVID & RSV Tests
Published: 2023-06-20 (Crawled : 20:00) - globenewswire.com
LMDX | $0.016 -15.0% 130M

| -95.43% | O: 30.46% H: 17.17% C: -2.98%
covid approval rsv

The REMM Group Designs Their New Orange County Corporate Headquarters for the Post COVID Work Style
Published: 2022-05-24 (Crawled : 20:00) - prnewswire.com
FNCTF | News | $11.0354 -20.84% 320

Communications

| Email alert Add to watchlist
covid work group designation

COVID-19 Testing No Longer Required for Vaccinated Travelers
Published: 2022-03-08 (Crawled : 20:00) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M

Manufacturing

| -82.48% | O: 5.73% H: 0.0% C: 0.0%
covid-19 travel covid test vaccine

Insights on the Intradermal Injection Global Market to 2028 - COVID-19 Impact and Analysis
Published: 2022-02-24 (Crawled : 20:00) - prnewswire.com
TRUMF | $16.928 -17.59% 1.9K

Health Technology

| -45.79% | O: 2.31% H: 0.0% C: -0.59%
TRUMY | $16.507 0.79% 34K

Manufacturing

| -46.71% | O: 1.31% H: 1.45% C: 1.45%
WST | $372.04 -1.4% 0.0% 440K

Health Technology

| -0.27% | O: -0.22% H: 2.39% C: 2.36%
covid-19 derm covid injection

Global Military Protective Eye-Wear Market Forecast to 2028 - COVID-19 Impact and Analysis
Published: 2022-02-24 (Crawled : 20:00) - prnewswire.com
GNTX | $33.91 0.98% 0.97% 1.3M

Producer Manufacturing

| 11.37% | O: 0.17% H: 0.0% C: 0.0%
covid-19 eye covid

Report: New Research from Paychex Reveals Workers' Top Concerns Around COVID-19 Variants
Published: 2022-02-23 (Crawled : 20:00) - prnewswire.com
PAYX 4 | $119.5 1.45% 1.43% 2.6M

Technology Services

| 4.87% | O: -1.73% H: 3.9% C: 3.72%
covid-19 als research covid work report

Positive Covid-19 Test
Published: 2022-02-18 (Crawled : 20:00) - taylordevices.com
TAYD A | $47.53 1.93% 1.89% 16K

Producer Manufacturing

| Email alert Add to watchlist
covid-19 covid test positive

Positive Covid-19 Test
Published: 2022-02-03 (Crawled : 20:00) - taylordevices.com
TAYD A | $47.53 1.93% 1.89% 16K

Producer Manufacturing

| Email alert Add to watchlist
covid-19 covid test positive

Positive Covid-19 Test
Published: 2022-01-21 (Crawled : 20:00) - taylordevices.com
TAYD A | $47.53 1.93% 1.89% 16K

Producer Manufacturing

| Email alert Add to watchlist
covid-19 covid test positive

First Wave BioPharma Completes Enrollment for Part 2 of RESERVOIR Phase 2 Trial Evaluating FW-COV in COVID-19-Related GI Infections
Published: 2022-01-06 (Crawled : 20:00) - biospace.com/
FWBI | $2.59 -8.8% -9.65% 83K

Manufacturing

| 85.62% | O: 0.0% H: 2.61% C: -3.92%
covid-19 phase 2 biopharma trial covid infection enroll infections

Moderna Announces Switzerland Exercises its Option to Purchase Seven Million Additional Doses of Moderna's COVID-19 Booster Vaccine in 2022
Published: 2021-12-27 (Crawled : 20:00) - biospace.com/
MRNA S | $101.44 -0.55% -0.55% 2.6M

Health Technology

| -58.62% | O: -2.8% H: 4.0% C: 1.6%
covid-19 covid switzerland vaccine

Pfizer Receives U.S. FDA Emergency Use Authorization for Novel COVID-19 Oral Antiviral Treatment
Published: 2021-12-22 (Crawled : 20:00) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M

Health Technology

| -56.88% | O: 0.51% H: 2.25% C: 0.51%
covid-19 treatment fda covid authorization antiviral merge emergency use authorization

Novavax Files NDA In Japan Following Phase III COVID Vaccine Trial Results
Published: 2021-12-17 (Crawled : 20:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M

Health Technology